[CGS 20267 (Letrozole), a new aromatase inhibitor: early phase II study for postmenopausal women with advanced breast cancer].
Year: 2002
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Institution: National Hospital Organization Kyushu Cancer Center
Language: Japanese
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2241234043
